indazoles has been researched along with cyclopropanecarboxamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bracey-Walker, MR; Britton, TC; Catlow, JT; Clark, BP; Dehlinger, V; Dressman, BA; Fivush, AM; Hao, J; Heinz, BA; Henry, SS; Hollinshead, SP; Iyengar, S; Love, PL; Massey, SM; McKinzie, DL; Monn, JA; Peng, L; Peters, SC; Roberts, EF; Rudyk, HC; Simmons, RM; Swanson, S; Tepool, AD; Vokits, BP | 1 |
1 other study(ies) available for indazoles and cyclopropanecarboxamide
Article | Year |
---|---|
Discovery of (1R,2R)-N-(4-(6-isopropylpyridin-2-yl)-3-(2-methyl-2H-indazol-5-yl)isothiazol-5-yl)-2-methylcyclopropanecarboxamide, a potent and orally efficacious mGlu5 receptor negative allosteric modulator.
Topics: Allosteric Regulation; Amides; Animals; Behavior, Animal; Cyclopropanes; Glutamic Acid; Indazoles; Male; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Thiazoles | 2013 |